Home Investors

 

 

 

The Management Team

The Company currently has a staff of six. As a group, the staff has extensive background in many aspects of medical service and product commercialization, in both new ventures and in large corporations.  In addition, the Company’s Board of Advisors includes individuals with extensive clinical, technical, and business experience. The following serve as executive officers of the Company.

 Christopher G. LaFarge, CEO:  A.B., Biology, Harvard College, 1977; MBA, Yale University, 1980; MFS, Yale University, 1980.  Mr. LaFarge has been the Founder/CEO of companies in several industries including forest products, oil and gas, and healthcare. He has successfully developed and brought to market a number of new products. His last company grew to a $50M market cap before its sale. Mr. LaFarge spent 3 years at Harvard Medical School and Beth Israel Hospital doing biomedical research.

Thomas Forest Farb, President: A.B., Harvard College, 1980. Tom Farb has been significantly involved in the founding, management and/or the initial financings of numerous companies and has participated in the private equity and venture capital industries. He was President & Chief Operating Officer of Indevus Pharmaceuticals (NASDAQ: IDEV), Lexington, MA, acquired by Endo Pharmaceuticals (NASDAQ: ENDP). He co-founded and was the Managing Director of the Boston and Shanghai-based private equity firm, New America Partners, LLC; was General Partner & CFO of the investment firm, Summit Partners; and VP Business Development and CFO of Cytyc Corporation (NASDAQ: CYTC).

Judson Pratt, VP Marketing:  BME, Tufts University, 1961; MBA, Tuck School Dartmouth, 1963. Jud Pratt has extensive experience in marketing, sales, and project management for healthcare information systems. He has created three healthcare IT products and brought them to market during his career as well as successfully starting and growing several healthcare IT companies.

Ute Schwiderski, VP Clinical R&D and Biometrics: Ph.D., Medical College of Virginia, B.S., Mathematics, University of Virginia. Ute Schwiderski has worked in the pharmaceutical industry for many years, most recently for Indevus Pharmaceuticals as VP Biostatistics and Data Management where she set up the department and was responsible for: project planning and management, biostatistics, statistical programming, data management, medical writing and document review functions; and previously for Bristol-Myers Squibb Company as Associate Director, Anti-Infective Biostatistics and Manager, CNS Biostatistics.

 

Cathie LeMaster, Project Manager and CRA: B.S., Purdue University. Cathie LeMaster has worked first with Millennium Pharmaceuticals and then with Indevus Pharmaceuticals as a Clinical Research Specialist, designing, planning and implementing clinical research projects for a variety of drugs trials, as well as in preparation of protocols, regulatory documentation, as well as site qualification, initiation and monitoring.

I. Peter Kellett , Dir Product Development :  BSEE, Lanchester College, UK 1966.  Peter Kellett is an electrical engineer with 35 years experience in electronics design and manufacture in USA and Europe. Mr. Kellett holds five patents in the fields of telecommunications, control and measurement. Born and educated in the UK, Kellett also lived and worked in France before immigrating to the US in 1970. He founded and ran Product Resources, Inc. until 2006  a well established electronics design and manufacturing company in Beverly Mass.

 

Board of Directors

Christopher LaFarge, Chairman

Judson Pratt, Director

Thomas Forest Farb, Director

Robert Schlesinger, MD, Director: Physics and Electrical Engineering degrees, Tufts University, 1956. MD, Tufts Medical School, 1964. Design engineer at Pratt & Whitney Aircraft. He has held academic or clinical appointments at Harvard, Boston University, and Tufts. Currently Director of Urology Services at two Boston teaching hospitals, and a surgeon.

Robert Horne, Director:  Mr. Horne has been a VP and General Manager for Vertical Market Solutions of Nortel Networks focusing on the Finance, Healthcare Retail, Hospitality and Education markets. While at Nortel, Mr. Horne spearheaded their venture capital investing activities. He has a Masters Degree in Chemical Engineering from Cambridge University, England, and an MBA from Harvard Business School.  His recent and prior Healthcare activities have included:

  • Given Imaging Inc. (GIVN), Atlanta, Georgia, serving in the capacity of Vice President Organization Development and advisor.

  • President and CEO of BioCAD Corporation, now part of Pharmacopeia (PCOP), a Sunnyvale, California, venture capital backed software company, focused on developing new pharmaceuticals.

  • General Manager of Accuray, Inc. (ARAY), a Santa Clara, California, venture capital backed company developing stereotactic radio surgery equipment.

  • Senior Vice President, Operations, TSI Corporation (NASDAQ) a supplier of pre-clinical, clinical and biological testing services to the healthcare industry;

 

[Home] [Investors]

Send mail to Webmaster with questions or comments about this web site.
Copyright © 2008 MedicaMetrix
Last updated:  12/04/08